Navigation Links
REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body
Date:2/4/2008

rash and/or joint pain.

There have been rare cases of serious liver injury in people taking REMICADE, some fatal. Tell your doctor if you have liver problems and contact your doctor immediately if you develop symptoms such as jaundice (yellow skin and eyes), dark brown urine, right-sided abdominal pain, fever or severe fatigue.

Blood disorders have been reported, some fatal. Tell your doctor if you develop possible signs of blood disorders such as persistent fever, bruising, bleeding or paleness while taking REMICADE. Nervous system disorders have also been reported. Tell your doctor if you have or have had a disease that affects the nervous system, or if you experience any numbness, weakness, tingling, visual disturbances or seizures while taking REMICADE.

Allergic reactions, some severe, have been reported during or after infusions with REMICADE. Signs of an allergic reaction include hives, difficulty breathing, chest pain, high or low blood pressure, swelling of face and hands, and fever or chills. Tell your doctor if you have experienced a severe allergic reaction. The most common side effects of REMICADE are: respiratory infections, such as sinus infections and sore throat, headache, rash, coughing and stomach pain.

Please read the Medication Guide for REMICADE and discuss it with your doctor.

About Centocor

Centocor is harnessing the power of world-leading research and biomanufacturing to deliver innovative biomedicines that transform patients' lives. Centocor has already brought innovation to the treatment of Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, pediatric Crohn's disease and psoriasis.

The world leader in monoclonal antibody production and technology, Centocor has brought critical biologic therapies to patients suffering from debilitating immune disorders.

(i) Reich K, Menter A, et al. Consistency of Infliximab Response Across

Subg
'/>"/>

SOURCE Centocor, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Observational Data Show Transfusion Patterns in Chemotherapy-Induced Anemia Patients Receiving Erythropoiesis-Stimulating Agents
2. TargeGen Announces Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients
3. JAK2 Inhibitor Shows Potent Activity in Cells From MPD Patients
4. Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors
5. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
6. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
7. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
8. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
9. Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent
10. Zevalin(R) Combined With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation (ASCT) Produces High Overall Survival and Progression-Free Survival Rates in Patients With Relapsed Non-Hodgkins Lymphoma
11. Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...,Nov.25/PRNewswire/--CempraPharmaceuticalsInc.toda...efexecutiveofficer,willpresentatthePiperJaffray21s...,2009,atTheNewYorkPalaceHotelinNewYorkCity.Dr.Fern...antibioticclinicalprogramsforthetreatmentofdrug-re...harmaceuticals ,, Foundedin2006,CempraPharmace...
(Date:11/25/2009)...landsandJOHANNESBURG,November25/PRNewswire/--,iThe...yannouncedtoday,thattheyhavesignedacollaborativeag..., Pyxis,sworldclasscomputationalchemistryandlead...cedivisiontoprovidemedicinaland,syntheticchemistry...onalclientnetwork.iThembaPharmaceuticalsandPyxisDi...
(Date:11/24/2009)...v.24/PRNewswire-Asia/--ChindexInternational,Inc.,(...canproviderofWestern,healthcareproductsandservices...eCompanywillattendthe21stAnnualPiperJaffray,"Unplu...,atthe,NewYorkPalaceHotel. , Managementiscurr...ber1,2009,andholdone-on-onemeetingsthroughouttheda...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Chindex International to Present at Piper Jaffray Health Care Conference 2YMCA Expands Pioneering Healthier Communities Initiative to Lead Healthy Change in Communities Nationwide 56595 1YMCA Expands Pioneering Healthier Communities Initiative to Lead Healthy Change in Communities Nationwide 56595 2YMCA Expands Pioneering Healthier Communities Initiative to Lead Healthy Change in Communities Nationwide 56595 3YMCA Expands Pioneering Healthier Communities Initiative to Lead Healthy Change in Communities Nationwide 56595 4YMCA Expands Pioneering Healthier Communities Initiative to Lead Healthy Change in Communities Nationwide 56595 5ATU Will Not Support 3A Health Care Plan Without Public Option Members of Congress Who Do Not Fight for It 56593 1ATU Will Not Support 3A Health Care Plan Without Public Option Members of Congress Who Do Not Fight for It 56593 2Study reveals new role of vitamin C in skin protection 56591 1Study reveals new role of vitamin C in skin protection 56591 2
(Date:11/25/2009)...atment clinics to resume Monday, Nov. 30 , ...009 -- Centegra Health System is continuing to off...our Centegra Primary Care (CPC) vaccination clinic...he clinics are at CPC sites in Huntley, Woodstock,...ows: ,   From 4:30 to 7:30 p.m. Tuesda...
(Date:11/25/2009)...wswire/--TheAmericanAssociationforHomecareendorses...chisdesignedtosubstantiallyimprovetoolsandresource...ducedbySen.GeorgeLeMieux(R-Fla.). ,, TheLeMieux...nforHomecareoutlinedinits13-pointanti-fraudactionp...y.Thoseprovisionsincludecallingforreal-timeauditsa...
(Date:11/25/2009)...mor cells, study finds , , WEDNESDAY, No...ed in a fingernail-size implant eliminated melanom...thod uses polymer disks, 8.5 millimeters in diamet...nd implanted under the skin to reprogram the immun...scientists who developed the implant predicted tha...
(Date:11/25/2009)...ll/--TheAdvisoryBoardCompany(Nasdaq: ABCO )announc...ffrayHealthCareConferenceinNewYorkCity.Speakingatt...heCompany,sChiefExecutiveOfficer,RobertW.Musslewhi...irshbaum.Thepresentationmaterialswillbeavailableon...rdcompany.com ,throughDecember16,2009. ,, Abou...
(Date:11/25/2009)...nielTouizer,CEOof Ci n e r gyHealth ,anation...tprograms,isconcernedthatthelabordepartment,srecen...rewithoutafull-timejobandunlikelytohavehealthinsur...heU-6number,whichhasspikedto17.5%,thehighestratein...tatisticsarealarmingasitmeansthatmanyAmericansdono...
Breaking Medicine News(10 mins):Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2Health News:Cinergy Health Commentary on Health Care for the Unemployed 2
...Mercy Prenatal, Cervical Cancer Screening Particip...t Card, PHILADELPHIA, Aug. 8 Keystone Mercy Heal...ization in Pennsylvania, in,conjunction with Delaw...ervices, celebrate National Health,Center Week by ...
...A, Va., Aug. 8 /PRNewswire-USNewswire/ National Ho...l Hospice Foundation honor the,recipients of the 2...d,celebrates innovation in end-of-life care and hi... annual summit in San Diego. This year,s Award win...
...evels of testosterone may be a key factor in sprea...The findings could help explain why males in a pop... transmit disease., , Previous research has linke...se, and account for a larger share of disease tran...
... 6, 2008 Oakland, Calif. Children,s Hospital & R...n pediatric rehabilitation with the creation of a ...ers. Jacob Neufeld, MD, MSPH, Medical Director of...iplinary Approach . The quarterly journal released...
..., Pa., Aug. 7 Eastern Insurance,Holdings, Inc. (N...oday that,it has executed a definitive agreement t...ubsidiaries ("Employers") in a transaction valued ...ompany, an Indianapolis, Indiana-based mono-line w...
... quarter of victims get to hospital quickly enough..., Aug. 7 (HealthDay News) -- Most people who have ...issolving treatment that can limit brain damage, a...ate professor of epidemiology at the University of...
Other Medicine News:Health News:Keystone Mercy and DVCH to Offer Screenings for National Health Center Week 2Health News:Circle of Life Awards Recognize Innovative End-of-Life Care Providers 2Health News:Circle of Life Awards Recognize Innovative End-of-Life Care Providers 3Health News:Testosterone key to disease transmission 2Health News:Children's Hospital Oakland publishes first of its kind pediatric rehabilitation journal 2Health News:Eastern Insurance Holdings, Inc. Announces Definitive Agreement to Acquire Employers Security Holding Company and Subsidiaries 2Health News:Eastern Insurance Holdings, Inc. Announces Definitive Agreement to Acquire Employers Security Holding Company and Subsidiaries 3Health News:Eastern Insurance Holdings, Inc. Announces Definitive Agreement to Acquire Employers Security Holding Company and Subsidiaries 4Health News:Many Miss Out on Stroke Treatment 2Health News:Many Miss Out on Stroke Treatment 3
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: